These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 34991618)

  • 1. Extracellular matrix-degrading STING nanoagonists for mild NIR-II photothermal-augmented chemodynamic-immunotherapy.
    Zhan M; Yu X; Zhao W; Peng Y; Peng S; Li J; Lu L
    J Nanobiotechnology; 2022 Jan; 20(1):23. PubMed ID: 34991618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactivable STING Nanoagonists to Synergize NIR-II Mild Photothermal Therapy Primed Robust and Long-Term Anticancer Immunity.
    Ma W; Sun R; Tang L; Li Z; Lin L; Mai Z; Chen G; Yu Z
    Adv Mater; 2023 Nov; 35(48):e2303149. PubMed ID: 37691545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decomposable Nanoagonists Enable NIR-Elicited cGAS-STING Activation for Tandem-Amplified Photodynamic-Metalloimmunotherapy.
    Guo X; Tu P; Wang X; Du C; Jiang W; Qiu X; Wang J; Chen L; Chen Y; Ren J
    Adv Mater; 2024 May; 36(21):e2313029. PubMed ID: 38353366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second near-infrared photothermal-amplified immunotherapy using photoactivatable composite nanostimulators.
    Sun H; Yu T; Li X; Lei Y; Li J; Wang X; Peng P; Ni D; Wang X; Luo Y
    J Nanobiotechnology; 2021 Dec; 19(1):433. PubMed ID: 34930269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy.
    Shae D; Becker KW; Christov P; Yun DS; Lytton-Jean AKR; Sevimli S; Ascano M; Kelley M; Johnson DB; Balko JM; Wilson JT
    Nat Nanotechnol; 2019 Mar; 14(3):269-278. PubMed ID: 30664751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second Near-Infrared Photothermal Semiconducting Polymer Nanoadjuvant for Enhanced Cancer Immunotherapy.
    Li J; Yu X; Jiang Y; He S; Zhang Y; Luo Y; Pu K
    Adv Mater; 2021 Jan; 33(4):e2003458. PubMed ID: 33325584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Near-Infrared II Phototherapy Induces Deep Tissue Immunogenic Cell Death and Potentiates Cancer Immunotherapy.
    Ma Y; Zhang Y; Li X; Zhao Y; Li M; Jiang W; Tang X; Dou J; Lu L; Wang F; Wang Y
    ACS Nano; 2019 Oct; 13(10):11967-11980. PubMed ID: 31553168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NIR-II fluorescence and PA imaging guided activation of STING pathway in photothermal therapy for boosting cancer immunotherapy by theranostic thermosensitive liposomes.
    Long Q; Yang Y; Liao F; Chen H; He D; Li S; Li P; Guo W; Xiao Y
    J Mater Chem B; 2023 Sep; 11(35):8528-8540. PubMed ID: 37608753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration.
    Wehbe M; Wang-Bishop L; Becker KW; Shae D; Baljon JJ; He X; Christov P; Boyd KL; Balko JM; Wilson JT
    J Control Release; 2021 Feb; 330():1118-1129. PubMed ID: 33189789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activatable polymer nanoagonist for second near-infrared photothermal immunotherapy of cancer.
    Jiang Y; Huang J; Xu C; Pu K
    Nat Commun; 2021 Feb; 12(1):742. PubMed ID: 33531498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 2D Nanoradiosensitizer Enhances Radiotherapy and Delivers STING Agonists to Potentiate Cancer Immunotherapy.
    Luo T; Nash GT; Jiang X; Feng X; Mao J; Liu J; Juloori A; Pearson AT; Lin W
    Adv Mater; 2022 Sep; 34(39):e2110588. PubMed ID: 35952624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma.
    Wang-Bishop L; Wehbe M; Shae D; James J; Hacker BC; Garland K; Chistov PP; Rafat M; Balko JM; Wilson JT
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32169869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetically Edited Cascade Nanozymes for Cancer Immunotherapy.
    Zhang J; Pan Y; Liu L; Xu Y; Zhao C; Liu W; Rao L
    ACS Nano; 2024 May; 18(19):12295-12310. PubMed ID: 38695532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activatable Immunoprotease Nanorestimulator for Second Near-Infrared Photothermal Immunotherapy of Cancer.
    Xu M; Zhang C; He S; Xu C; Wei X; Pu K
    ACS Nano; 2023 May; 17(9):8183-8194. PubMed ID: 37122103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STING Activator c-di-GMP-Loaded Mesoporous Silica Nanoparticles Enhance Immunotherapy Against Breast Cancer.
    Chen YP; Xu L; Tang TW; Chen CH; Zheng QH; Liu TP; Mou CY; Wu CH; Wu SH
    ACS Appl Mater Interfaces; 2020 Dec; 12(51):56741-56752. PubMed ID: 33305564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NIR-II responsive PEGylated nickel nanoclusters for photothermal enhanced chemodynamic synergistic oncotherapy.
    Qian Y; Zhang J; Zou J; Wang X; Meng X; Liu H; Lin Y; Chen Q; Sun L; Lin W; Wang H
    Theranostics; 2022; 12(8):3690-3702. PubMed ID: 35664059
    [No Abstract]   [Full Text] [Related]  

  • 17. Apoptotic Body-Mediated Intracellular Delivery Strategy for Enhanced STING Activation and Improved Tumor Immunogenicity.
    Bao P; Zheng ZT; Ye JJ; Zhang XZ
    Nano Lett; 2022 Mar; 22(6):2217-2227. PubMed ID: 35254071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer.
    Cheng N; Watkins-Schulz R; Junkins RD; David CN; Johnson BM; Montgomery SA; Peine KJ; Darr DB; Yuan H; McKinnon KP; Liu Q; Miao L; Huang L; Bachelder EM; Ainslie KM; Ting JP
    JCI Insight; 2018 Nov; 3(22):. PubMed ID: 30429378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photothermal Ferrotherapy - Induced Immunogenic Cell Death via Iron-Based Ternary Chalcogenide Nanoparticles Against Triple-Negative Breast Cancer.
    Wu Q; Li Z; Zhou X; Wei Z; Ramadan S; Xu Y; Xu L; Li D
    Small; 2024 May; 20(20):e2306766. PubMed ID: 38095479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade.
    Yang H; Lee WS; Kong SJ; Kim CG; Kim JH; Chang SK; Kim S; Kim G; Chon HJ; Kim C
    J Clin Invest; 2019 Jul; 129(10):4350-4364. PubMed ID: 31343989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.